Development of a CXCR4 antagonistic peptide, P12, to suppress pancreatic cancer progress via enhancing T cell responses and sensitizing cells to gemcitabine

开发一种CXCR4拮抗肽P12，通过增强T细胞反应和提高细胞对吉西他滨的敏感性来抑制胰腺癌的进展。